You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創機器人-B(02252.HK):微創®支氣管鏡手術機器人完成首例人體臨牀試驗

格隆匯4月1日丨微創機器人-B(02252.HK)公佈,由公司聯合四川大學華西醫院(“華西醫院”)和上海市胸科醫院自主研發的機器人輔助支氣管鏡導航系統(“微創®支氣管鏡手術機器人”)在華西醫院李為民教授、劉丹教授及其團隊主導下,成功完成了一例機器人輔助經支氣管鏡肺結節活檢術。這是國產支氣管鏡手術機器人完成的首例人體臨牀試驗。

微創®支氣管鏡手術機器人是一種無創經自然腔道機器人手術平台。系統具有超柔順,超纖細蛇形機器人導管,可通過人體自然腔道,以無體表創傷的方式進入難以觸及的狹窄病灶空間,對肺部微小結節等癌症早期病變的早診早治具有重要意義。

微創®支氣管鏡手術機器人首例臨牀手術的成功,是國產手術機器人在無創經自然腔道領域實現的首例手術突破,也標誌着公司在微創傷手術領域的又一重大里程碑,是對公司底層技術體系和前沿創新能力的又一次證明。

公司將繼續加強與臨牀專家的緊密合作,深化前沿探索和技術創新,加快國產支氣管鏡手術機器人的臨牀應用和技術迭代,加速肺部疾病智能手術機器人全解方案的產業化推進。同時,公司將以支氣管鏡手術機器人為新的起點,拓展在經自然腔道介入領域的臨牀應用,為中國以及全球的患者和醫生提供能夠延長和重塑生命的機器人智慧手術全解方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account